Speak directly to the analyst to clarify any post sales queries you may have.
The test kits market in Europe is forecasted to decrease by USD -17.29 bn during 2022-2027, accelerating at a CAGR of -23.8% during the forecast period. The report on the test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing government funding, rising focus on preventing the spread of COVID-19 pandemic, and increasing number of strategic alliances.
The test kits market in Europe is segmented as below:
By End-user
- Government
- Non-government
By Type
- Rapid test kit
- RT-PCR
- Others
This study identifies the advent of SARS-CoV-2 mutation as one of the prime reasons driving the test kits market in Europe growth during the next few years. Also, increasing demand for point-of-care diagnostics and rising adoption of rapid diagnostic products will lead to sizable demand in the market.
The report on the test kits market in Europe covers the following areas:
- Test kits market in Europe sizing
- Test kits market in Europe forecast
- Test kits market in Europe industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc., Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, PerkinElmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED. Also, the test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The research team recognises the following companies as the key players in the test kits market in Europe: 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc., Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, PerkinElmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED.One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is advent of SARS-CoV-2 mutation.'
According to the report, one of the major drivers for this market is the increasing government funding.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Biomedicine Science and Technology Co. Ltd.
- Abbott Laboratories
- altona Diagnostics GmbH
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- BIOSYNEX SA
- Bruker Corp.
- Co Diagnostics Inc.
- Danaher Corp.
- Edinburgh Genetics Ltd.
- F. Hoffmann La Roche Ltd.
- MultiplexDX
- PerkinElmer Inc.
- QIAGEN NV
- Robert Bosch GmbH
- Sd Biosensor Inc.
- Seegene Inc.
- Thermo Fisher Scientific Inc.
- ZEKMED